Senate Republican questions FDA chief on counterfeit weight loss drugs
Sen. Jim Banks (R-Ind.) wants the Food and Drug Administration to look into foreign-made active pharmaceutical ingredients he says are being included online weight loss drugs.
In a letter to acting FDA Commissioner Sara Brenner, Banks warned that the nation is seeing a spike in drugs with the foreign-made ingredients that could post health risks for Americans purchasing them online.
'Booming online gray and black markets are flooding the country with knock-off and counterfeit GLP-1s contaminated with foreign-made APIs [active pharmaceutical ingredients], and few Americans purchasing these drugs are aware of the risks they pose,' Banks wrote in th Wednesday letter.
'I request detailed information about how the Food and Drug Administration (FDA) will prevent unlawful APIs from entering the country and potentially harming Americans,' he added.
GLP-1s refers to compounded glucagon-like peptide 1 agonist medications — injectable weight-loss drugs.
Banks in the letter said the FDA's Adverse Event Reporting System database as of the end of last year had recorded more than 900 cases of adverse health events associated with the matter, which he said was four times the number see in the 2022 fiscal year. Seventeen of those cases involved deaths, Banks wrote.
Banks wrote that faulty medications were enters the country because of a lack of FDA assessment at points of entry.
'These drugs come in formulations that the FDA has never approved, have inconsistent doses, misrepresent injectable insulin as semaglutide, contain contaminants, or are in reality completely different drugs,' the Indiana senator said.
Those selling such drugs must be shut down, he added.
Banks's letter to Brenner asks how the FDA will work with U.S. Customs and Border Protection to prevent counterfeit drugs from entering the United States while educating communities about the difference between authentic and knock off drugs.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
22 minutes ago
- Yahoo
REGN Strengthens Obesity Pipeline: Will the Move Revive the Stock?
Regeneron Pharmaceuticals, Inc. REGN is looking to make inroads in the lucrative obesity market. The company recently entered into an in-licensing agreement for an obesity drug with Hansoh Pharmaceuticals Group Company Limited, in a bid to expand its clinical-stage obesity portfolio. The licensing agreement with Hansoh Pharma provides Regeneron with HS-20094, a GLP-1/GIP receptor agonist. Regeneron will acquire exclusive clinical development and commercial rights for HS-20094, a dual GLP-1/GIP receptor agonist, outside the Chinese Mainland, Hong Kong and Macau. Per the terms of the agreement, Regeneron will make an upfront payment of $80 million to Hansoh, with potential additional payments of up to $1.93 billion for achievement of development, regulatory and sales milestones. Any royalties on global net sales in the future (outside the designated territories) would be in the low double digits. HS-20094 has been evaluated in over 1,000 patients and administered as a weekly subcutaneous injection. The candidate has demonstrated promising efficacy and safety clinical data, suggesting a potentially similar profile to the only FDA-approved GLP-1/GIP receptor agonist. The candidate is currently being evaluated in a phase III study in obesity in China, and a phase IIb study in diabetes is ongoing. The in-licensing agreement for an obesity candidate will expand REGN's obesity pipeline, which includes trevogrumab. Regeneron recently announced positive interim results from the ongoing phase II COURAGE study investigating novel combinations of semaglutide (GLP-1 receptor agonist) and trevogrumab (anti-GDF8/anti-myostatin) with or without garetosmab (anti-activin A) for the treatment of obesity. COURAGE was designed to investigate the quality of weight loss in patients with obesity. Results showed that approximately 35% of semaglutide-induced weight loss was due to loss of lean mass, and further demonstrated that combining semaglutide with trevogrumab with or without garetosmab helped preserve lean mass while increasing loss of fat mass. Garetosmab is being evaluated for the treatment of fibrodysplasia ossificans progressive. The successful development of any obesity treatment will be a great boost for the company. We note that REGN has had a rough time so far this year. The stock got hammered last week after REGN and partner Sanofi SNY reported results from two late-stage studies, AERIFY-1 and AERIFY-2, on itepekimab for the treatment of chronic obstructive pulmonary disease (COPD). While the AERIFY-1 study met the primary endpoint, AERIFY-2 did not meet the same. REGN and SNY are currently reviewing the data and plan to discuss the next steps with regulatory authorities. Year to date, REGN's shares have lost 31.7% compared with the industry's 3.2% decline. Image Source: Zacks Investment Research Regeneron's performance in the first quarter was dismal. The plunge in Eylea sales adversely impacted the top line. Eylea sales have been under pressure for some time now due to competition from Roche's Vabysmo. Regeneron Pharmaceuticals, Inc. price-consensus-eps-surprise-chart | Regeneron Pharmaceuticals, Inc. Quote Regeneron has a tough road ahead, as it will take a long time for Eylea HD to contribute significantly to the top line. Apart from Eylea, profits from the sales of asthma drug Dupixent are a primary growth driver for REGN. Regeneron has a collaboration agreement with Sanofi for Dupixent. While the obesity market is lucrative, REGN is a pretty late entrant here. The market is dominated by bigwigs like Novo Nordisk NVO and Eli Lilly LLY. The stupendous success of Novo Nordisk's obesity drug, Wegovy (semaglutide) and Eli Lilly's Zepbound has prompted many companies to join the bandwagon. Buoyed by this success, both Lilly and NVO have taken significant strides in developing their obesity portfolios further. Given the significant market potential of obesity, other players are also striving to grab a chunk of this pie. Regeneron currently has a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Regeneron Pharmaceuticals, Inc. (REGN) : Free Stock Analysis Report Sanofi (SNY) : Free Stock Analysis Report Novo Nordisk A/S (NVO) : Free Stock Analysis Report Eli Lilly and Company (LLY) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research
Newsweek
an hour ago
- Newsweek
These Are the Best and Worst States for Aging in Place
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. A new report from Seniorly ranked the best and worst states for aging at home for seniors, and Florida surprisingly earned the lowest spot of all. "These findings reinforce what we already know," one expert told Newsweek, "aging well isn't just about personal health; it's also about where you live and what resources that place can provide." As millions of Americans turn 65 this year, more and more are hoping to continue living in their homes rather than move to assisted living facilities or retirement homes. In 2025, a record 4.2 million Americans will reach senior age, and 75 percent of older Americans said they wanted to stay living in their own homes in a recent AARP survey. Why It Matters Many Americans hope to stay at home to maintain their independence and remain in the communities where they've already built support systems. However, not all locations make this easiest for seniors, as cost of living, transportation, and access to high-quality health care all play a role in whether a senior is able to successfully live outside of a retirement home. Shirley Gooding, a physical Therapy Aid, helps William Rexroat, a WWII Navy veteran exercise during a physical therapy session at the Quincy Veterans Home February 17, 2005, in Quincy, Illinois. Shirley Gooding, a physical Therapy Aid, helps William Rexroat, a WWII Navy veteran exercise during a physical therapy session at the Quincy Veterans Home February 17, 2005, in Quincy, To Know Best States Utah took the best state spot for aging in place, as only 35 percent of seniors live alone. They also have relatively good weather, with just 10.1 inches of rain and snow each year on average. The state also had a significant level of smart home tech use at 37 percent. The top 10 state list for seniors was as follows: Utah North Dakota New Jersey Idaho Texas Nebraska California New Mexico Kansas Washington Seniorly's list was compiled using data on home health care quality and availability, emergency care services, housing costs, road safety, walkability, weather hazards and more. They also took into account the risk of isolation, as roughly 43 percent of U.S. seniors live alone. The top states generally had short ER wait times, with North Dakota coming in at second place, as well as a high level of meal deliveries for older Americans. Home care quality also mattered, with 31 percent of New Jersey's agencies earning a 4.5 or 5-star rating. Worst States Meanwhile, the worst states for aging in places were as follows: Florida Kentucky North Carolina Georgia Alabama Tennessee Mississippi Vermont Oklahoma Hawaii Many retirees may be surprised to find Florida ranked the lowest for aging in place. This is because of its limited access to home health aides, with 50 seniors per available aide. Floridians also deal with high housing costs, with 30.7 percent of older homeowners spending more than 30 percent of their income on housing. The state also experiences high precipitation of 53 inches annually, which could heighten safety risks for seniors. The other Southern states ranked low struggled for different reasons. Kentucky had one of the highest rates of fatal car crashes involving seniors, at 28.2 deaths per 100,000 drivers. Meanwhile, seniors in North Carolina spent an average of 195 minutes in the emergency room, longer than nearly all other states. "What is definitely eye-opening is how many Southern states ranked near the bottom," Kevin Thompson, the CEO of 9i Capital Group and the host of the 9innings podcast, told Newsweek. "These are states with historically high poverty rates and heavy reliance on social insurance programs." What People Are Saying Drew Powers, the founder of Illinois-based Powers Financial Group, told Newsweek: "Utah ranks first and Florida ranks last. Does that mean we should always retire in Utah and never in Florida? Not really. The bottom line is aging in place requires a network, and aging seniors need to be located where their network is located. Aside from being financially prepared for longevity, access to both skilled and non-skilled assistance is the key and is most likely to come from family and close friends." Kevin Thompson, the CEO of 9i Capital Group and the host of the 9innings podcast, told Newsweek: "There's a clear relationship between income and aging outcomes. The wealthier the state, the more likely it is to support aging in place through quality care, better roads, and stronger support systems. These findings reinforce what we already know: aging well isn't just about personal health, it's also about where you live and what resources that place can provide." Alex Beene, a financial literacy instructor for the University of Tennessee at Martin, told Newsweek: "What's most surprising about these rankings are how perceptions do not always equal reality with America's aging population. Florida has been for decades perceived as a haven for retirees; however, in the years following the pandemic, housing costs have risen dramatically and the state has been slow to adopt the home health measures other states have to better medically serve their communities." What Happens Next From 2025 to 2050, the number of people aged 65 and older is expected to skyrocket from 63.3 million to 82.1 million. "States like Utah benefit from more seniors being less alone and having more access to smart home features that assist in the aging process," Beene said. "At the end of the day, aging isn't just about saving some tax dollars. It's about the overall quality of life."
Yahoo
an hour ago
- Yahoo
‘I'm Treating Guys Who Would Never Be Caught Dead in a Casino'
Gambling has swallowed American sports culture whole. Until early 2018, sports betting was illegal under federal law; today, it's legal in 39 states and Washington, D.C. (and easy enough to access through backdoor channels even in the states where it isn't). During NFL games, gambling commercials air more often than ads for beer. Commentators analyze not just whether a team can win, but if they might win by at least the number of points by which they're favored on betting apps. Nearly half of men younger than 50 now have an account with an online sports book, and Americans spent about $150 billion on sports wagers last year. I regularly get ads on my phone offering me a complimentary $200 in sports bets, as long as I gamble $5 first. As betting has overrun American sports, other forms of gambling are also on the rise. According to industry data, American casinos are more popular now than at any point on record. The age of their average patron had been crawling upward for years, but since sports betting was legalized at the federal level, it has plummeted by nearly a decade, to approximately 42. Some signs point to gambling problems increasing, too. No centralized entity tracks gambling addiction, but if its scale comes even close to matching the new scale of sports betting, the United States is unequipped to deal with it. In its power to ruin and even end lives, gambling addiction is remarkably similar to drug dependency. Imaging studies show that pathological gamblers and people with substance addictions share patterns of brain activity. They are more likely to experience liver disease, heart disease, and sleep deprivation, whether it originates in the anxiety of concealing a gambling addiction or because someone is up wagering on contests, such as cricket and table tennis, that happen in faraway time zones. The best national survey available, which dates to well before the rise of sports betting, found that 2 million to 4 million Americans will experience a gambling disorder at some point in their life; one in six people with a gambling disorder attempts suicide. Even if their death certificate says differently, 'I've had several patients who died because of the emotional pain from their gambling disorder,' Timothy Fong, a psychiatrist specializing in addiction treatment and a co-director of UCLA's gambling-studies program, told me. Fong, like the other researchers I spoke with, said that rapid forms of gambling, especially those that allow you to place multiple bets at one time, tend to be especially addictive. For decades, sports betting mostly involved wagers on who'd win a match, by how much, and total points scored—outcomes resolved over the course of hours. Now apps offer endless in-game bets decided in seconds. Last year, I watched the Super Bowl with a friend who bet on the national anthem lasting less than 90.5 seconds—the smart money, according to the analysts. He lost when Reba McEntire belted the song's last words twice. The ability to place one bet after another encourages a hallmark behavior of problem gamblers—when deep in the red, instead of walking away, they bet bigger. 'Viewing sports gambling as a way to make money is likely to end badly,' Joshua Grubbs, a gambling researcher at the University of New Mexico, told me. 'Gamblers that think that gambling is a way toward economic success or financial payouts almost always have far more problem-gambling symptoms.' And some apps actively blur the already hazy line between betting and other financial activities. For instance, the financial platform Robinhood, where millions of people trade meme stocks and manage their retirement accounts, began offering online sports 'events contracts' (a type of investment whose payout depends on traders' correctly predicting the outcome of a specified event) during March Madness this year through a partnership with the financial exchange Kalshi. (A Robinhood spokesperson told me this 'emergent asset class' differs significantly from sports betting because users, not the house, set the prices, and can more easily exit their positions. But the experience of 'investing' in an events contract is virtually indistinguishable from betting.) Financial markets have recently started offering services like this even in states where sports betting is illegal. State gambling regulators have called foul, but the federal government has so far made no move to stop the companies. As the courts sort out whether any of this is legal, Robinhood decided to let customers trade on the Indy 500 and the French Open. Several recent trends suggest that problem gambling might be on the rise in the U.S. Calls to state gambling helplines have increased. (This might be partly explained by advocacy groups marketing their helplines more aggressively than ever; gambling companies also tack the numbers onto their ubiquitous ads.) Fong said that he was recently invited to speak to a consortium of family lawyers, whose divorce clients have started asking, 'How do I protect my children from the damage of their father's gambling?' Researchers and counselors are especially worried about single young men who play in fantasy sports leagues, bet on sports, day trade, and consider gambling a good way to make money. Gamblers Anonymous is rolling out groups for young people. 'I'm treating guys who would never be caught dead in a casino,' James Whelan, a clinical psychologist who runs treatment clinics for gambling addiction in Tennessee, told me. [Read: How casinos enable gambling addicts] These imperfect proxy measures, along with incomplete data trickling out of a few states, are the best indicators that researchers have about the extent of gambling addiction. Experts are also unsure how long any increase in problem gambling might last: Some studies suggest that the prevalence of gambling problems tends to equalize after a spike, but those findings are usually limited to physical casinos and remain debated within the field. According to researchers I spoke with, no study has established the prevalence of gambling addiction in the U.S. since sports betting became widespread. Federal agencies dedicated to alcoholism and substance abuse allocate billions of research dollars to American universities every year. Yet for decades, the federal government—the largest funder of American research—has earmarked zero dollars for research on gambling activity or addiction specifically, despite collecting millions annually from gambling taxes. (The Substance Abuse and Mental Health Services Administration, which collects national data on behavioral health and funds research into it, declined to comment.) Gambling-addiction treatment is '50 years behind where we are with drugs or alcohol or any other substance,' Michael Sciandra, the executive director of the Nebraska Council on Problem Gambling, told me. Doctors and therapists, even those who specialize in treating addiction, rarely screen for issues with gambling, he said. Among the handful of dedicated gambling-addiction treatment providers around the country, many deploy cognitive behavioral therapy, which studies suggest can at least temporarily improve patients' quality of life and reduce the severity of their gambling problem. But discrepancies in treatment approaches and tiny trial sizes make it difficult to say exactly how many patients the therapy helps. Two medications used to treat alcoholism and opioid addiction have also been found to reduce the severity of gambling addiction across a handful of small clinical trials. But the evidence needed for FDA approval would require large and expensive clinical trials that no one seems eager to fund, Marc Potenza, the director of Yale's Center of Excellence in Gambling Research, told me. Because the federal government doesn't fund gambling-addiction treatment, each state decides what resources to make available. A Tennessee caller to the national helpline 1-800-GAMBLER might be put through to their state's helpline and then connected to the network of government-subsidized clinics Whelan runs across the state. But in states with bare-bones offerings, workers typically refer callers to peer-support groups such as Gamblers Anonymous, or to online resources on budgeting, says Cole Wogoman, a director at the National Council on Problem Gambling, which runs the helpline. Studies have found that each of these strategies is less effective than therapy. [Charles Fain Lehman: Legalizing sports gambling was a huge mistake] Texas could be an example of how unprepared the U.S. is to deal with any increase in problem gamblers. The state's gambling laws are among the strictest in the country, and yet it still sends the second-highest number of callers (behind California) to 1-800-GAMBLER. This November, Texans might vote on a constitutional amendment to allow sports betting. The state of more than 30 million has no funding for gambling treatment and only three certified gambling counselors, according to Carol Ann Maner, who is one of them. The state's official hub for gambling help, which Maner leads, was founded just this spring. Once they find the money, Maner and her colleagues plan to finally set up the state's own helpline. But first, they need to recruit and train more therapists for a job that, thanks to a lack of state and federal funding, might require turning away uninsured clients. That's a daunting task. Finding the apps Texans can use to get around gambling restrictions is easy. Article originally published at The Atlantic
